Simian adenoviral vectors (SAd) offer an attractive alternative to standard human adenovirus serotype 5 (AdH5) subunit vaccination, due to pre-existing immunity affecting vaccine performance. We have used a mouse model of liver-stage malaria to test the efficiency of three chimpanzee-origin adenoviral vectors, AdC6, AdC7 and AdC9 containing ME.TRAP as an insert. AdC7 and AdC9 elicited strong immunogenicity ( approximately 20% of CD8(+) T cells in spleen), equivalent to or outperforming AdH5 a...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record